1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Esclerosis Múltiple

Esclerosis Múltiple

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • Órpez-Zafra T, Pavía J, Hurtado-Guerrero I, Pinto-Medel MJ, Rodriguez Bada JL, Urbaneja P, Suardíaz M, Villar LM, Comabella M, Montalban X, Alvarez-Cermeño JC, Leyva L, Fernández Ó, Oliver-Martos B.

    Decreased soluble IFN-ß receptor (sIFNAR2) in multiple sclerosis patients: A potential serum diagnostic biomarker.

    MULTIPLE SCLEROSIS JOURNAL . 23(7): 937-945. Nº de citas: 7

    [doi:10.1177/1352458516667564]

  • Carrillo-Salinas FJ, Mestre L, Mecha M, Feliú A, Del Campo R, Villarrubia N, Espejo C, Montalbán X, Álvarez-Cermeño JC, Villar LM, Guaza C.

    Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus.

    SCIENTIFIC REPORTS . 7: 44377-44377. Nº de citas: 29

    [doi:10.1038/srep44377]

  • Villoslada P, Alonso C, Agirrezabal I, Kotelnikova E, Zubizarreta I, Pulido-Valdeolivas I, Saiz A, Comabella M, Montalban X, Villar L, Alvarez-Cermeño JC, Fernández O, Alvarez-Lafuente R, Arroyo R, Castro A.

    Metabolomic signatures associated with disease severity in multiple sclerosis.

    Neurology(R) neuroimmunology & neuroinflammation . 4(2): .

    [doi:10.1212/NXI.0000000000000321]

  • Matute-Blanch C, Río J, Villar LM, Midaglia L, Malhotra S, Álvarez-Cermeño JC, Vidal-Jordana A, Montalban X, Comabella M.

    Chitinase 3-like 1 is associated with the response to interferon-beta treatment in multiple sclerosis.

    JOURNAL OF NEUROIMMUNOLOGY . 303: 62-65. Nº de citas: 12

    [doi:10.1016/j.jneuroim.2016.12.006]

  • Fernández-Pablos MA, Costa-Frossard L, García-Hernández C, García-Montes I, Escutia-Roig M, Grupo de enfermeras expertas en el manejo de los síntomas asociados a la espasti.

    Manejo de los síntomas asociados a la espasticidad en pacientes con esclerosis múltiple.

    ENFERMERIA CLINICA . 26(6): 367-373. Nº de citas: 2

    [doi:10.1016/j.enfcli.2016.06.009]

  • Arrambide G, Espejo C, Eixarch H, Villar LM, Alvarez-Cermeño JC, Picón C, Kuhle J, Disanto G, Kappos L, Sastre-Garriga J, Pareto D, Simon E, Comabella M, Río J, Nos C, Tur C, Castilló J, Vidal-Jordana A, Galán I, Arévalo MJ, Auger C, Rovira A, Montalban X, Tintore M.

    Neurofilament light chain level is a weak risk factor for the development of MS.

    Neurology . 87(11): 1076-1084. Nº de citas: 66

    [doi:10.1212/WNL.0000000000003085]

  • Sadovnick AD, Traboulsee AL, Bernales CQ, Ross JP, Forwell AL, Yee IM, Guillot-Noel L, Fontaine B, Cournu-Rebeix I, Alcina A, Fedetz M, Izquierdo G, Matesanz F, Hilven K, Dubois B, Goris A, Astobiza I, Alloza I, Antigüedad A, Vandenbroeck K, Akkad DA, Aktas O, Blaschke P, Buttmann M, Chan A, Epplen JT, Gerdes LA, Kroner A, Kubisch C, Kümpfel T, Lohse P, Rieckmann P, Zettl UK, Zipp F, Bertram L, Lill CM, Fernandez O, Urbaneja P, Leyva L, Alvarez-Cermeño JC, Arroyo R, Garagorri AM, García-Martínez A, Villar LM, Urcelay E, Malhotra S, Montalban X, Comabella M, Berger T, Fazekas F, Reindl M, Schmied MC, Zimprich A, Vilarino-Guell C.

    Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.

    G3-GENES GENOMES GENETICS . 6(7): 2073-2079. Nº de citas: 8

    [doi:10.1534/g3.116.030841]

  • Fernandez O, Rodriguez-Antiguedad A, Olascoaga J, Oreja-Guevara C, Prieto JM, Mendibe-Bilbao MM, Garcia-Merino JA, Ramio-Torrenta L, Ginestal R, Meca-Lallana JE, Romero-Pinel L, Munoz D, Saiz A, Calles-Hernandez MC, Izquierdo G, Villar LM, Oliva-Nacarino P, Arnal-Garcia C, Comabella M, Brieva L, Arroyo R, Montalban X.

    Review of the novelties from the 31st ECTRIMS Congress, 2015, presented at the 8th Post-ECTRIMS meeting.

    REVISTA DE NEUROLOGIA . 62(12): 559-569. Nº de citas: 8

    [doi:10.33588/rn.6212.2016196]

  • Sainz-de-la-Maza S, Casado JL, Pérez-Elías MJ, Moreno A, Quereda C, Moreno S, Corral I.

    Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.

    EUROPEAN JOURNAL OF NEUROLOGY . 23(5): 919-925. Nº de citas: 19

    [doi:10.1111/ene.12963]

  • Martínez-Rodríguez JE, Cobo-Calvo A, Villar LM, Munteis E, Blanco Y, Rasal R, Vera A, Muntasell A, Alvarez-Lafuente R, Saiz A, Alvarez-Cermeño JC, Martínez-Yélamos S, Roquer J, López-Botet M.

    Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis

    MULTIPLE SCLEROSIS JOURNAL . 22(6): 741-752. Nº de citas: 16

    [doi:10.1177/1352458515601215]

  • Escobar-Villalba A, Sainz de la Maza S, Pérez Torre P, Galán JC, Rodríguez-Domínguez M, Monreal Laguillo E, Martínez Ulloa PL, Buisán Catevilla J, Corral I.

    Acute myelitis by human herpes virus 7 in an HIV-infected patient.

    JOURNAL OF CLINICAL VIROLOGY . 77: 63-65. Nº de citas: 8

    [doi:10.1016/j.jcv.2016.02.001]

  • de Bock L, Fraussen J, Villar LM, Álvarez-Cermeño JC, Van Wijmeersch B, van Pesch V, Stinissen P, Somers V.

    Anti-SPAG16 antibodies in primary progressive multiple sclerosis are associated with an elevated progression index

    EUROPEAN JOURNAL OF NEUROLOGY . 23(4): 722-728. Nº de citas: 8

    [doi:10.1111/ene.12925]

  • Bravo García-Morato M, Padilla-Merlano B, Nozal P, Espiño M, Juárez C, Villar LM, López-Trascasa M.

    Laboratory guidelines for the diagnosis and follow-up of patients with monoclonal gammopathies

    REVISTA CLINICA ESPANOLA . 216(3): 128-134.

    [doi:10.1016/j.rce.2015.09.002]

  • Álvarez-Cermeño JC, Muñoz-Negrete FJ, Costa-Frossard L, de la Maza SS, Villar LM, Rebolleda G.

    Intrathecal lipid-specific oligoclonal IgM synthesis associates with retinal axonal loss in multiple sclerosis.

    JOURNAL OF THE NEUROLOGICAL SCIENCES . 360: 41-44. Nº de citas: 10

    [doi:10.1016/j.jns.2015.11.030]

  • Comabella M, Cantó E, Nurtdinov R, Río J, Villar LM, Picón C, Castilló J, Fissolo N, Aymerich X, Auger C, Rovira A, Montalban X.

    MRI phenotypes with high neurodegeneration are associated with peripheral blood B-cell changes

    HUMAN MOLECULAR GENETICS . 25(2): 308-316. Nº de citas: 23

    [doi:10.1093/hmg/ddv473]

  • Sellebjerg F, Cadavid D, Steiner D, Villar LM, Reynolds R, Mikol D.

    Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis.

    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS . 9(1): 31-43. Nº de citas: 22

    [doi:10.1177/1756285615615257]

  • Borràs E, Cantó E, Choi M, Villar LM, Álvarez-Cermeño JC, Chiva C, Montalban X, Vitek O, Comabella M, Sabidó E.

    Protein-Based Classifier to Predict Conversion from Clinically Isolated Syndrome to Multiple Sclerosis

    MOLECULAR & CELLULAR PROTEOMICS . 15(1): 318-328. Nº de citas: 20

    [doi:10.1074/mcp.M115.053256]

  • Bustamante MF, Morcillo-Suárez C, Malhotra S, Rio J, Leyva L, Fernández O, Zettl UK, Killestein J, Brassat D, García-Merino JA, Sánchez AJ, Urcelay E, Alvarez-Lafuente R, Villar LM, Alvarez-Cermeño JC, Farré X, Lechner-Scott J, Vandenbroeck K, Rodríguez-Antigüedad A, Drulovic JS, Martinelli Boneschi F, Chan A, Oksenberg J, Navarro A, Montalban X, Comabella M.

    Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-ß.

    Neurology(R) neuroimmunology & neuroinflammation . 2(5): . Nº de citas: 16

    [doi:10.1212/NXI.0000000000000154]